BEXIMCO PHARMA.GDR REGS 1 logo

BEXIMCO PHARMA.GDR REGS 1 (R2WA)

Market Closed
10 Jan, 20:00
XBER XBER
0. 43
-0
-0.47%
21.2B Market Cap
- P/E Ratio
12.7% Div Yield
0 Volume
- Eps
0.43
Previous Close
Day Range
0.43 0.43
Year Range
0.23 0.46
Earnings results expected in 13 days

Summary

R2WA closed Friday lower at €0.43, a decrease of 0.47% from Thursday's close, completing a monthly decrease of -2.29% or €0.01. Over the past 12 months, R2WA stock lost -2.29%.
R2WA is not paying dividends to its shareholders.
The last earnings report, released on Nov 04, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jan 28, 2025.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XBER (EUR).
Want to track R2WA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

R2WA Chart

FAQ

What Is the BEXIMCO PHARMA.GDR REGS 1(R2WA) Stock Price Today?

The R2WA stock price today is €0.43.

What Stock Exchange Does BEXIMCO PHARMA.GDR REGS 1 Trade On?

BEXIMCO PHARMA.GDR REGS 1 is listed and trades on the XFRA.

What Is the Stock Symbol for BEXIMCO PHARMA.GDR REGS 1?

The stock symbol for BEXIMCO PHARMA.GDR REGS 1 is "R2WA".

Does BEXIMCO PHARMA.GDR REGS 1 Pay Dividends? What's The Current Dividend Yield?

R2WA is not paying dividends to its shareholders.

What Is the BEXIMCO PHARMA.GDR REGS 1 Market Cap?

As of today, BEXIMCO PHARMA.GDR REGS 1 market cap is 21.2B.

What is BEXIMCO PHARMA.GDR REGS 1 Earnings Per Share?

The BEXIMCO PHARMA.GDR REGS 1 EPS is 0.

What Is the Next BEXIMCO PHARMA.GDR REGS 1 Earnings Date?

BEXIMCO PHARMA.GDR REGS 1 will release its next earnings report on Jan 28, 2025.

Did BEXIMCO PHARMA.GDR REGS 1 had any splits?

No, BEXIMCO PHARMA.GDR REGS 1 has never had a stock split.

BEXIMCO PHARMA.GDR REGS 1 Profile

Drug Manufacturers—Specialty & Generic Industry
Healthcare Sector
- CEO
XBER Exchange
US0885792061 ISIN
Bangladesh Country
5,500 Employees
22 Nov 2024 Last Dividend
- Last Split
- IPO Date
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Contact Information

Address: 19 Dhanmondi R/A
Phone: 880 2 5861 1001